期刊文献+

Xanthogranulomatous cholecystitis:a premalignant condition? 被引量:11

Xanthogranulomatous cholecystitis:a premalignant condition?
下载PDF
导出
摘要 BACKGROUND:Xanthogranulomatous cholecystitis(XGC)is an uncommon variant of chronic cholecystitis,characterized by marked thickening of the gallbladder wall and dense local adhesions.It often mimics a gallbladder carcinoma(GBC), and may coexist with GBC,leading to a diagnostic dilemma. Furthermore,the premalignant nature of this entity is not known.This study was undertaken to assess the p53,PCNA and beta-catenin expression in XGC in comparison to GBC and chronic inflammation. METHODS:Sections from paraffin-embedded blocks of surgically resected specimens of GBC(69 cases),XGC(65), chronic cholecystitis(18)and control gallbladder(10)were stained with the monoclonal antibodies to p53 and PCNA, and a polyclonal antibody to beta-catenin.p53 expression was scored as the percentage of nuclei stained.PCNA expression was scored as the product of the percentage of nuclei stained and the intensity of the staining(1-3).A cut-off value of 80 for this score was taken as a positive result. Beta-catenin expression was scored as type of expression-membranous,cytoplasmic or nuclear staining. RESULTS:p53 mutation was positive in 52%of GBC cases and 3%of XGC,but was not expressed in chronic cholecystitis and control gallbladders.p53 expression was lower in XGC than in GBC(P<0.0001).PCNA expression was seen in 65%of GBC cases and 11%of XGC,but not in chronic cholecystitis and control gallbladders.PCNA expression was higher in GBC than XGC(P=0.0001),but there was no significant difference between the XGC,chronic cholecystitis and control gallbladder groups.Beta-catenin expression was positive in the GBC,XGC, chronic cholecystitis and control gallbladder groups.But the expression pattern in XGC,chronic cholecystitis and control gallbladders was homogenously membranous,whereas in GBC the membranous expression pattern was altered to cytoplasmic and nuclear.CONCLUSION:The expression of p53,PCNA and beta-catenin in XGC was significantly different from GBC and similar to chronic cholecystitis,thus indicating the inflammatory nature of XGC and may not support a premalignant nature of the lesion. BACKGROUND:Xanthogranulomatous cholecystitis(XGC)is an uncommon variant of chronic cholecystitis,characterized by marked thickening of the gallbladder wall and dense local adhesions.It often mimics a gallbladder carcinoma(GBC), and may coexist with GBC,leading to a diagnostic dilemma. Furthermore,the premalignant nature of this entity is not known.This study was undertaken to assess the p53,PCNA and beta-catenin expression in XGC in comparison to GBC and chronic inflammation. METHODS:Sections from paraffin-embedded blocks of surgically resected specimens of GBC(69 cases),XGC(65), chronic cholecystitis(18)and control gallbladder(10)were stained with the monoclonal antibodies to p53 and PCNA, and a polyclonal antibody to beta-catenin.p53 expression was scored as the percentage of nuclei stained.PCNA expression was scored as the product of the percentage of nuclei stained and the intensity of the staining(1-3).A cut-off value of 80 for this score was taken as a positive result. Beta-catenin expression was scored as type of expression-membranous,cytoplasmic or nuclear staining. RESULTS:p53 mutation was positive in 52%of GBC cases and 3%of XGC,but was not expressed in chronic cholecystitis and control gallbladders.p53 expression was lower in XGC than in GBC(P<0.0001).PCNA expression was seen in 65%of GBC cases and 11%of XGC,but not in chronic cholecystitis and control gallbladders.PCNA expression was higher in GBC than XGC(P=0.0001),but there was no significant difference between the XGC,chronic cholecystitis and control gallbladder groups.Beta-catenin expression was positive in the GBC,XGC, chronic cholecystitis and control gallbladder groups.But the expression pattern in XGC,chronic cholecystitis and control gallbladders was homogenously membranous,whereas in GBC the membranous expression pattern was altered to cytoplasmic and nuclear.CONCLUSION:The expression of p53,PCNA and beta-catenin in XGC was significantly different from GBC and similar to chronic cholecystitis,thus indicating the inflammatory nature of XGC and may not support a premalignant nature of the lesion.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2011年第2期179-184,共6页 国际肝胆胰疾病杂志(英文版)
基金 support from the Department of Science and Technology,Ministry of Science&Technology,Government of India,Fast Track Scheme
关键词 xanthogranulomatous cholecystitis gallbladder cancer P53 PCNA BETA-CATENIN xanthogranulomatous cholecystitis gallbladder cancer p53 PCNA beta-catenin
  • 相关文献

参考文献2

二级参考文献26

  • 1[1]Kwon AH, Matsui Y, Uemura Y. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis. JAm Coll Surg 2004; 199:204-210
  • 2[2]Furuta A, Ishibashi T, Takahashi S, Sakamoto K. MR imaging of xanthogranulomatous cholecystitis. Radiat Med 1996; 14:315-319
  • 3[3]Enomoto T, Todoroki T, Koike N, Kawamoto T, Matsumoto H. Xanthogranulomatous cholecystitis mimicking stage Ⅳgallbladder cancer. Hepatogastroenterology 2003; 50:1255-1258
  • 4[4]Pinocy J, Lange A, Konig C, Kaiserling E, Becker HD, Krober SM. Xanthogranulomatous cholecystitis resembling carcinoma with extensive tumorous infiltration of the liver and colon.Langenbecks Arch Surg 2003; 388:48-51
  • 5[5]Maeda T, Shimada M, Matsumata T, Adachi E, Taketomi A, Tashiro Y, Tsuneyoshi M, Sueishi K, Sugimachi K.Xanthogranulomatous cholecystitis masquerading as gallbladder carcinoma. Am J Gastroenterol 1994; 89:628-630
  • 6[6]Natori S, Takimoto A, Endoh K, Ishikawa T, Yamaguchi S,Fjii Y, Takahashi T, Takeda K, Watarai S, Nakano A, Kitamura H, Shimada H. A case of xanthogranulomatous cholecystitis difficult to be differentiated from gallbladder cancer. Tann to Sui 1997; 18: 593-596.
  • 7[7]Okamoto S, Konan T, Yamaguchi K, Nakamura K,Maeda S, Kitamura K. Xanthogranulomatous cholecystitis masquerading as gallbladder carcinoma. Tann to Sui 1990; 11:1415-1419
  • 8[8]Guzman-Valdivia G. Xanthogranulomatous cholecystitis: 15years' experience. World J Surg 2004; 28:254-257
  • 9[9]Fligiel S, Lewin KJ. Xanthogranulomatous cholecystitis: case report and review of the literature. Arch Pathol Lab Med 1982;106:302-304
  • 10[10]Muguruma N, Okamura S, Okahisa T, Shibata H, Ito S, Yagi K. Endoscopic sonography in the diagnosis of xanthogranulomatous cholecystitis. J Clin Ultrasound 1999; 27:347-350

共引文献70

同被引文献61

引证文献11

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部